| A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment RM Ghazy, A Almaghraby, R Shaaban, A Kamal, H Beshir, A Moursi, ... Scientific Reports 10 (1), 1-18, 2020 | 126 | 2020 |
| Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial A Kamal, AA Abd Elmoety, YAM Rostom, MS Shater, SA Lashen Journal of Gastrointestinal Oncology 10 (3), 562, 2019 | 76 | 2019 |
| A Meta-Analysis on the Safety and Immunogenicity of CovId-19 vaccines R Ashmawy, NA Hamdy, YAM Elhadi, ST Alqutub, OF Esmail, ... Journal of primary care & community health 13, 21501319221089255, 2022 | 24 | 2022 |
| Endoscopic variceal ligation followed by argon plasma coagulation against endoscopic variceal ligation alone: a randomized controlled trial A Kamal, AAA Elmoety, Y Hamza, A Zeid Journal of clinical gastroenterology 51 (1), 49-55, 2017 | 19 | 2017 |
| COVID-19 Vaccine Acceptance among Social Media Users: A Content Analysis, Multi-Continent Study R Shaaban, RM Ghazy, F Elsherif, N Ali, Y Yakoub, MO Aly, ... International Journal of Environmental Research and Public Health 19 (9), 5737, 2022 | 18 | 2022 |
| Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial A Kamal, RM Ghazy, D Sherief, A Ismail, WI Ellakany BMC Infectious Diseases 23 (1), 1-8, 2023 | 11 | 2023 |
| Effectiveness and Safety of Chloroquine or Hydroxychloroquine as a mono-therapy or in combination with Azithromycin in the treatment of COVID-19 patients: Systematic Review and … RM Ghazy, A Elmaghraby, R Shaaban, A Kamal, H Beshir, A Moursi, ... medRxiv, 2020 | 10 | 2020 |
| Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate A Kamal, A Elsheaita, M Abdelnabi World Journal of Clinical Cases 10 (6), 1764, 2022 | 6 | 2022 |
| Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: a 2-year follow-up study A Kamal, AA Abd Elmoety, YA Rostom, MS Shater, SA Lashen Clinical and Experimental Hepatology 7 (1), 66-73, 2021 | 3 | 2021 |
| Galectin-3 is not useful for hepatocellular carcinoma surveillance in cirrhotic patients but it may be a marker of cirrhosis development ES Nassar, YA Elkalbashawy, A Kamal, NHE Zakaria Clinical and Experimental Hepatology 7 (1), 74-78, 2021 | 3 | 2021 |
| P0167: Endoscopic variceal ligation followed by argon plasma coagulation versus endoscopic variceal ligation alone: A randomized controlled trial A Abd Elmoety, Y Hamza, A Zeid, A Kamal, R Ibrahim, A Sidkey, M Badr Journal of Hepatology, S365, 2015 | 3 | 2015 |
| Tolloid-like 1 gene variant rs17047200, pretreatment FIB-4, ALBI and PALBI scores as predictors of hepatocellular carcinoma occurrence after directly acting antivirals A Kamal, A Mohsin, C Matta, R Ghazy, A Elhadidi, M Tahoun, A Rahal, ... Clinical and Experimental Hepatology 8 (4), 330-334, 0 | 2 | |
| Acute Hepatitis Caused by Genotype 4 HCV Presenting with Microangiopathic Hemolytic Anemia A Kamal, AH Youssef, AR Mansour ACG case reports journal 5, 2018 | 1 | 2018 |
| Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population N Elmansoury, AA Megahed, A Kamal, N El-Nikhely, M Labane, ... Genes 15 (4), 455, 2024 | | 2024 |
| Hepatitis C Virus-Related One-Year Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial A Kamal, M Metawea, H Omar, M Ghallab, A Kassem, H Naguib Journal of Gastrointestinal Cancer, 1-11, 2024 | | 2024 |
| ASSESSING PREDICTORS OF DIRECTLY ACTING ANTIVIRALS’FAILURE AS A FURTHER STEP TOWARDS MORE EFFICIENT HCV ELIMINATION PROGRAMS: IL28B (IFNL4) GENE POLYMORPHISM HAS NO ROLE WHILE … A Kamal, C Matta, HA Mohsin, AS Elhadidi, RM Ghazy, HH Omar, ... Arquivos de Gastroenterologia 59, 177-183, 2022 | | 2022 |
| Avaliação dos preditores da falha dos antivirais de ação direta como mais um passo para programas de eliminação de VHC mais eficiente: o polimorfismo genético IL28B (IFNL4) não … A KAMAL, C MATTA, HA MOHSIN, AS ELHADIDI, RM GHAZY, HH OMAR, ... Arquivos de Gastroenterologia 59, 177-183, 2022 | | 2022 |
| Relation between levels of toll-like receptors 3 and 7 and clinical profile of Child-Pugh B cirrhotic patients A Kamal, A Ramadan, D Sherief, A Hassan, N Nosair, M Mabrouk, ... Clinical and Experimental Hepatology 7 (3), 293-296, 2021 | | 2021 |
| Evaluation of A Novel Index That Incorporates Both Neutrophil-Lymphocyte Ratio and C-Reactive Protein for The Detection of Spontaneous Bacterial Peritonitis A Kamal, I Moheb, EM Hassouna, EE El-Gohary, RAHA Elwafa The Egyptian Journal of Hospital Medicine (January 2024) 94, 950-956, 0 | | |
